Mannkind (MNKD) Total Debt (2010 - 2026)
Mannkind (MNKD) reported Total Debt of $103.2 million for Q1 2026, down 0.55% year-over-year from $103.8 million in Q1 2025, and little changed quarter-over-quarter from $103.4 million in Q4 2025.
Mannkind (MNKD) Total Debt (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Total Debt data on file, last reported at $103.2 million in Q1 2026.
- Total Debt for Q1 2026 came in at $103.2 million, down 0.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.2 million (down 0.55% YoY), and the FY2025 annual result was $103.4 million, changed 0.5% from the prior year.
- Total Debt was little changed at $103.2 million in Q1 2026 per MNKD's latest filing, from $103.4 million in the prior quarter.
- Over five years, Total Debt peaked at $104.1 million in Q4 2023 and troughed at $8.8 million in Q4 2022.
- A 5-year average of $78.4 million and a median of $103.6 million in 2025 frame the typical range for Total Debt.
- The sharpest annual moves came in 2023 and 2025: Total Debt surged 1079.17% in 2023, then retreated 19.49% in 2025.
- A 5-year view of Total Debt shows it stood at $8.8 million in 2022, then surged by 1079.17% to $104.1 million in 2023, then retreated by 0.16% to $103.9 million in 2024, then retreated by 0.5% to $103.4 million in 2025, then declined by 0.22% to $103.2 million in 2026.
- Business Quant data shows MNKD's Total Debt at $103.2 million in Q1 2026, $103.4 million in Q4 2025, and $83.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 103.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.19 Mn |
| Dec 31, 2025 | 103.42 Mn |
| Sep 30, 2025 | 83.73 Mn |
| Jun 30, 2025 | 103.70 Mn |
| Mar 31, 2025 | 103.77 Mn |
| Dec 31, 2024 | 103.94 Mn |
| Sep 30, 2024 | 104.00 Mn |
| Jun 30, 2024 | 104.00 Mn |
| Dec 31, 2023 | 104.11 Mn |
| Sep 30, 2023 | 8.83 Mn |
| Jun 30, 2023 | 8.83 Mn |
| Dec 31, 2022 | 8.83 Mn |
| Jun 30, 2021 | 4.87 Mn |
| Mar 31, 2021 | 4.87 Mn |
| Dec 31, 2020 | 4.87 Mn |
| Sep 30, 2020 | 1.42 Mn |
| Jun 30, 2020 | 2.03 Mn |
| Jun 30, 2019 | 80.96 Mn |
| Mar 31, 2019 | 83.42 Mn |
| Dec 31, 2018 | 83.39 Mn |